SUBSCRIBE
SUBSCRIBE

LinusBio

NEWS
Map of NextGen Class of 2024/BioSpace
Business
NextGen Class of 2024: Top Life Sciences Startups to Watch This Year
Rapport Therapeutics tops this year’s list with $250 million in Series A and B financing in just six months.
January 3, 2024
 · 
20 min read
 · 
BioSpace Editorial Staff
IN THE PRESS
Press Releases
A New Era in Early Autism Support: LinusBio and Autism Speaks Partner to Promote Earlier Autism Diagnosis and Intervention
April 17, 2025
 · 
5 min read
Press Releases
LinusBio and The BRAIN Foundation Partner to Advance Biomarker-Supported Autism Diagnosis and Early Intervention
April 2, 2025
 · 
4 min read
Press Releases
Groundbreaking Autism Biomarker: LinusBio Launches ClearStrand-ASD to aid Health Care Providers in Ruling Out Autism Using a Single Strand of Hair
February 6, 2025
 · 
4 min read
Pharm Country
Semaphore Solutions’ Labbit Laboratory Informatics Solution Plays a Pivotal Role in Enhancing LinusBio’s Innovative Diagnostic Platform, Following LinusBio’s $25.5 Million Series A Funding Round
October 26, 2023
 · 
3 min read
AWARDS
  • NextGen Badge - Brighspot Rework_NextGen - Class of 2024.jpg
JOBS